Month: March 2026

Stock selection in pharmacy is a strategic decision that influences clinical credibility, category performance, professional positioning and long-term brand alignment.

Pharmacy owners and head office teams should evaluate a wound care supplier through a commercial and professional lens rather than being unduly influenced by promotional pricing.

Strategic context: the evolving role of pharmacy

Community pharmacy is the most accessible form of primary healthcare with more locations and longer opening hours than other providers. No wonder then, that it continues to expand its role in Australian primary healthcare with an increasing scope of practice that includes prescribing and vaccinating as well as compounding and dispensing. 

In wound care alone, patients seek advice from their pharmacist for minor wounds, post-procedural care, chronic wound support and dressing selection. 

Wounds Australia reports that 450,000 Australians suffer from chronic wounds. On average, each patient pays approximately $4,000 out-of-pocket each year for wound care. Those with venous leg ulcers or diabetic foot ulcers face even higher costs.

In this context, wound care forms an important part of the professional healthcare offering within pharmacy. Wounds UK highlights the importance of pharmacy teams understanding wound management principles and appropriate dressing selection to support safe care and referral where required. 

The opportunity beyond first aid

Some pharmacy suppliers focus exclusively on first aid. These brands often have no footprint in medical or hospital markets and are positioned primarily as retail consumer products.

Medstock differs in several material ways:

  • Clinicians founded and direct the business
  • Product architecture reflects clinical categories, not just retail segmentation
  • The portfolio spans both basic and advanced wound care, catering to a wider range of pharmacy clients
  • Products are supplied across medical, aged care and hospital environments, providing clinical continuity

Our clinically relevant portfolio supports professional positioning and enables pharmacy teams to offer solutions beyond adhesive strips and basic bandaging.

A clinically grounded wound care partner

A supplier that aligns with professional healthcare standards, supports workflow efficiency, and enables category expansion contributes to both clinical service delivery and commercial resilience in pharmacy.

Medstock delivers: 

  • Clinical relevance: A wound care portfolio that extends into advanced dressings, silicone technologies, alginates and hydrocolloids. This supports the considerable number of patients who require more than minor first aid.
  • Credibility through cross-sector presence: Medstock is not only active across pharmacy, medical and hospital channels. We also hold a NSW Health contract for wound care, casting and compression products, and our products are included on the Commonwealth Government’s Chronic Wound Consumables Scheme. Together, these markers strengthen Medstock’s credibility as a supplier operating beyond retail and within formal government procurement and care pathways.
  • Structured product architecture: Clear product naming and colour identification systems support operational efficiency and ease of recognition for pharmacy teams.

Commercial considerations

From a commercial standpoint, decision-makers typically assess:

  • Category margin potential
  • Differentiation versus competitors
  • Long-term supplier stability
  • Range breadth
  • Brand credibility at point of sale

Products that do not offer clear differentiation are often treated as interchangeable, leading to increased price sensitivity and margin pressure.

A clinically grounded brand allows pharmacies to:

  • Position wound care as a professional service
  • Support higher value dressing categories
  • Reduce direct comparison with purely price-driven first aid brands
  • Enhance professional trust with customers

Our structured, clinically coherent portfolio also reduces risk by:

  • Simplifying product identification to enable more accurate advice
  • Supporting staff confidence
  • Aligning with established wound care frameworks

Corporate social responsibility and brand alignment

Modern pharmacy procurement increasingly considers supplier values alongside commercial metrics.

Medstock’s continued partnership with Save Our Supplies demonstrates our ongoing commitment to reducing medical waste and supporting global health initiatives.

This collaboration means:

  • Suitable medical supplies that can no longer be sold are redirected to healthcare services overseas
  • Extended life and impact of these products 
  • Practical support for communities with limited access to essential medical resources 

Aligning with responsible suppliers supports corporate governance frameworks and community positioning. 

A strategic supplier decision for long-term category strength

Wound care is not a transactional retail category. It sits at the intersection of clinical service, professional trust and commercial performance.

Choosing Medstock supports pharmacies to:

  • strengthen the clinical integrity of the category
  • differentiate from price-driven competitors
  • support more informed patient conversations

Cross-sector credibility reinforces trust at the counter. Structured product architecture improves operational clarity for teams. Responsible supply initiatives reflect the standards increasingly expected of modern healthcare organisations.

Medstock’s position beyond retail pharmacy is further supported by its NSW Health contract and the inclusion of Medstock products on the Commonwealth Government’s Chronic Wound Consumables Scheme product list.

The wound care category can remain a commoditised retail aisle, or it can evolve into a more professionally led healthcare offering. Supplier choice plays a meaningful role in shaping that direction.

Please contact the Medstock team for further discussion.  

Disclaimer

This information is intended for healthcare professionals. 

References: